Literature DB >> 21312275

Parkinson's disease sleep scale--validation of the revised version PDSS-2.

Claudia Trenkwalder1, Ralf Kohnen, Birgit Högl, Vinod Metta, Friederike Sixel-Döring, Birgit Frauscher, Julia Hülsmann, Pablo Martinez-Martin, Kallol Ray Chaudhuri.   

Abstract

BACKGROUND: The previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients.
OBJECTIVE: To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea.
METHODS: For validation of the PDSS-2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS-2 was repeated for test-retest-reliability after 1-3 days.
RESULTS: A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2-40) indicating mild to moderate sleep disturbances. PDSS-2 item-total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) "motor problems at night," (2) "PD symptoms at night" and (3) "disturbed sleep." The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test-retest-reliability intra-class-coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS-2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out.
CONCLUSION: The PDSS-2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment-responsive tool for measuring sleep disorders in PD.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21312275     DOI: 10.1002/mds.23476

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  102 in total

1.  Factors Associated With Ambulatory Activity in De Novo Parkinson Disease.

Authors:  Cory Christiansen; Charity Moore; Margaret Schenkman; Benzi Kluger; Wendy Kohrt; Anthony Delitto; Brian Berman; Deborah Hall; Deborah Josbeno; Cynthia Poon; Julie Robichaud; Toby Wellington; Samay Jain; Cynthia Comella; Daniel Corcos; Ed Melanson
Journal:  J Neurol Phys Ther       Date:  2017-04       Impact factor: 3.649

2.  Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale.

Authors:  M T Pellecchia; A Antonini; U Bonuccelli; G Fabbrini; L Ferini Strambi; F Stocchi; A Battaglia; P Barone
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

Review 3.  Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Authors:  Benzi M Kluger; Karen Herlofson; Kelvin L Chou; Jau-Shin Lou; Christopher G Goetz; Anthony E Lang; Daniel Weintraub; Joseph Friedman
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

4.  Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?

Authors:  Rachael Purri; Laura Brennan; Jacqueline Rick; Sharon X Xie; Benjamin L Deck; Lana M Chahine; Nabila Dahodwala; Alice Chen-Plotkin; John E Duda; James F Morley; Rizwan S Akhtar; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub
Journal:  Mov Disord       Date:  2020-06-10       Impact factor: 10.338

5.  Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.

Authors:  Simone Goebel; Elisabeth Steinmann; Bernd Leplow; H Maximilian Mehdorn
Journal:  Neurol Sci       Date:  2018-04-14       Impact factor: 3.307

Review 6.  Therapies for Restless Legs in Parkinson's Disease.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2019-11-09       Impact factor: 3.598

7.  A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion.

Authors:  Maurizio Zibetti; Alberto Romagnolo; Aristide Merola; Lorenzo Priano; Elisa Montanaro; Serena Angrisano; Antonella Tribolo; Alessandro Cicolin; Leonardo Lopiano
Journal:  J Neurol       Date:  2017-04-19       Impact factor: 4.849

Review 8.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 9.  Parkinson's disease and sleep/wake disturbances.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

10.  Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.

Authors:  Fabian Büchele; Marc Hackius; Sebastian R Schreglmann; Wolfgang Omlor; Esther Werth; Angelina Maric; Lukas L Imbach; Stefan Hägele-Link; Daniel Waldvogel; Christian R Baumann
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.